Clinical Trials Logo

Inflammation clinical trials

View clinical trials related to Inflammation.

Filter by:

NCT ID: NCT00182338 Completed - Clinical trials for Cardiovascular Diseases

Evaluation of Volume Status in Peritoneal Dialysis Patients

Start date: January 2005
Phase: N/A
Study type: Observational

Patients with kidney failure on dialysis have a much higher risk of developing cardiovascular disease as compared to the general population. Recently, two large studies have shown that increasing the amount of dialysis does not decrease cardiovascular disease. It is known that retaining too much fluid leads to high blood pressure and thickening of the heart wall. Peritoneal dialysis is a method of home dialysis which allows dialysis patients autonomy and independence. This study will measure blood levels of a protein called N-BNP and measure the extent of body fluid by a machine called a bioimpedance analyzer. This device administers an undetectible electric current which distributes throughout total body water. The relationship between these tests and the clinical presence of volume expansion will be assessed. In addition, the extent of total body fluid and it's impact on heart attacks, heart failure and stroke will be determined.

NCT ID: NCT00180661 Completed - Asthma Clinical Trials

Inflammation and Corticosteroid Responsiveness in Severe Asthma

SARP
Start date: August 2003
Phase:
Study type: Observational

Some patients with mild asthma may develop severe asthma. It is not known what makes patients with mild asthma become severe, and we plan to find out why this happens. Patients with severe asthma may have a different type of inflammation in the airway tubes. Patients with severe asthma do not get as much benefit from taking steroid inhalers or tablets compared to asthma patients with mild disease. The study hypothesis is that the inflammation in severe asthma is such that it makes steroids less effective in treating asthma. We will find out what possible abnormalities there are in the blood cells and the bronchoalveolar macrophage cells in the lungs of patients with severe asthma compared to those with mild or moderate asthma.

NCT ID: NCT00175565 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Inhaled Steroid Reduces Systemic Inflammation in COPD

Start date: January 2002
Phase: Phase 4
Study type: Interventional

Systemic inflammation is present in chronic obstructive pulmonary disease (COPD), which has been linked to cardiovascular morbidity and mortality. We determined the effects of oral and inhaled corticosteroids on serum markers of inflammation in patients with stable COPD.

NCT ID: NCT00173823 Recruiting - Inflammation Clinical Trials

Malnutrition and Inflammation in Dialysis Patients in Taiwan

Start date: June 2004
Phase: N/A
Study type: Observational

According to the reports of the United States Renal Data System (USRDS), there is a 25% annual mortality rate with nearly 50% of all reported maintenance hemodialysis (HD) patient deaths attributed to atherosclerosis-related complications. Although traditional risk factors of cardiovascular disease (CVD) are common in end-stage renal disease (ESRD) patients, they alone may be insufficient to account for their high prevalence of CVD. Recent evidence demonstrated high plasma homocysteine levels have been established as a risk factor of chronic inflammation and atherosclerosis in patients with ESRD. Malnutrition and inflammation was associated with poor quality of life, morbidity and mortality. We, the researchers at National Taiwan University Hospital, hope to establish the best predictive profile of HD patient outcome. Thus, we establish several protocols to complete this work.

NCT ID: NCT00170729 Completed - Cataract Surgery Clinical Trials

A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery

Start date: August 17, 2004
Phase: Phase 4
Study type: Interventional

The primary objective was to demonstrate that two days of treatment with 0.5% prednisolone acetate eye-drops after cataract surgery are superior to vehicle in reducing the flare in the anterior chamber of the operated eye.

NCT ID: NCT00169923 Withdrawn - Inflammation Clinical Trials

Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease

Hercules
Start date: April 2007
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study in patients with stage 4 and 5 chronic kidney disease is to determine whether rosiglitazone can reduce inflammatory markers and to investigate its effect on intima media thickness, calcification and pulse wave velocity.

NCT ID: NCT00162825 Completed - Inflammation Clinical Trials

Role of CD7 in Skin Inflammation and Psoriasis

Start date: January 2004
Phase: N/A
Study type: Observational

Role of CD7 in skin inflammation and psoriasis

NCT ID: NCT00155350 Recruiting - Inflammation Clinical Trials

Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients

Start date: November 2004
Phase: Phase 4
Study type: Interventional

In this study, we, the investigators at National Taiwan University Hospital, will evaluate the efficacy of pharmacological therapy targeted to reduce insulin resistance (pioglitazone) on the progression and compositional change of non-obstructive coronary atherosclerotic plaques and coronary calcification by serial intravascular ultrasound (IVUS)/multi-detector-row computed tomography (MDCT) follow-up in patients with type 2 diabetes or non-diabetic metabolic syndrome during a 2-year period.

NCT ID: NCT00143650 Completed - Clinical trials for Upper Airway, Irritation Inflammation, Discomfort

SENOC-I Det Sunda Huset II - Sensitization of Occupants of Water Damaged Buildings.

Start date: January 2001
Phase: Phase 1/Phase 2
Study type: Interventional

The study is focussed on two main questions: 1. The importance of dampness of the building and home dust as a factor of the subjects= responses. 2. Can measures used in KLINIR predict the subjects’ responses to the dust? This study therefore was arranged to test the following hypotheses: 1. Does dust in general cause inflammatory/body perceptions through e.g. an irritation symptoms index. 2. Does the dust include effective odorants which affects an IAQ index? 3. Does dampness increase the content of organic or inorganic compounds e.g. of microbial origin that causes the dust to be more reactive? (Differences between the two types of dust) 4. Is the sensitivity of the subjects explaining the responses to exposures in a, b, or c? (Subject group and sensitivity index) As explorative investigations biomarkers for exposures and sensitivity for practical usage are tested.

NCT ID: NCT00142194 Completed - Atrial Fibrillation Clinical Trials

Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation

Start date: June 2005
Phase: Phase 1
Study type: Observational

Atrial fibrillation is an abnormal heart beat that starts in the upper parts of the heart and can cause stroke or death, if untreated. In general, treatments are not very effective, with frequent relapses of the abnormal heart beats. One explanation for the high relapse rate is that the treatments might not address the underlying cause of atrial fibrillation. Recently, the investigators have found that atrial fibrillation is associated with increased oxidative stress. This is a condition where abnormal oxygen forms are produced. These forms harm the cells of the heart, causing them to beat abnormally. The investigators have found increased oxidative stress in pig and mouse models of atrial fibrillation. They would like to see if oxidative stress is present in humans with atrial fibrillation. In this study, they will compare blood markers of oxidative stress between patients with and without atrial fibrillation. It is the expectation that participants with atrial fibrillation will have more abnormal blood markers of atrial fibrillation. This study requires participants to visit their doctors, undergo a history and physical examination, and give blood only once.